Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.560
-0.200 (-5.32%)
At close: Jul 10, 2026, 4:00 PM EDT
3.570
+0.010 (0.28%)
After-hours: Jul 10, 2026, 6:12 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.89 billion as of July 10, 2026. Its market cap has decreased by -10.01% in one year.
Market Cap
1.89B
Enterprise Value
1.31B
1-Year Change
-10.01%
Ranking
Category
Stock Price
$3.56
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.89B, a decrease of -62.77%. That is a compound annual growth rate of -17.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.89B | -11.24% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Generate Biomedicines | 2.03B |
| Stoke Therapeutics | 2.03B |
| Monte Rosa Therapeutics | 2.03B |
| Lakefront Biotherapeutics NV | 2.01B |
| Rapport Therapeutics | 2.01B |
| Sionna Therapeutics | 1.99B |
| Kardigan | 1.99B |
| Precigen | 1.98B |